Shalapour et al. identified the key TGFβR signaling immunosuppressive B cells in prostate cancer as plasma cells expressing IgA, IL-10, and PD-L1, which are involved in tumor immune tolerance 68. This evidence concerns the gene CD79A and neoplasm.